University of Manchester scientists have discovered previously unseen blood biomarkers which could one day be used to test for Alzheimer’s disease, years before its symptoms appear.

The ground-breaking study, published in ACS Nano, used cutting-edge nanotechnology uniquely developed and patented by the Nanomedicine Lab in Manchester, to extract blood signals of neurodegeneration in a mouse model of Alzheimer’s disease. The study was funded by the Medical Research Council.

Tests that capture early signs of neurodegeneration in blood offer enormous potential for Alzheimer’s disease and other dementia patients to receive effective treatment or manage effectively their progressive condition before significant brain damage occurs.

Read more.

Categories: Industry News